NASDAQ : RCKT
Rocket Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Last price 2.54 USD (Oct 29, 2026, 4:00 PM EDT) · Market cap 278.83M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 67.52M | 86.50M | 101.96M | 70.32M | 58.77M | 41.77M |
| Research & Development | 124.37M | 142.01M | 171.24M | 186.34M | 165.07M | 124.48M |
| Operating Expenses | 191.88M | 228.52M | 273.20M | 256.66M | 223.84M | 166.25M |
| Operating Income | -191.88M | -228.52M | -273.20M | -256.66M | -223.84M | -166.25M |
| Interest Expense | -1.89M | -1.89M | -1.89M | -1.88M | -1.86M | -2.98M |
| Interest & Investment Income | 1.91M | 3.22M | 8.27M | 5.29M | 3.89M | 3.07M |
| EBT Excluding Unusual Items | -191.87M | -227.19M | -266.82M | -253.25M | -221.82M | -166.16M |
| Merger & Restructuring Charges | 240.00K | -3.23M | -3.00M | |||
| Gain (Loss) on Sale of Investments | 4.81M | 7.30M | 8.08M | 10.65M | -47.00K | -2.91M |
| Pretax Income | -8.63M | -223.12M | -258.75M | -245.59M | -221.86M | -169.07M |
| Net Income | -17.25M | -223.12M | -258.75M | -245.59M | -221.86M | -169.07M |
| Net Income to Common | -17.25M | -223.12M | -258.75M | -245.59M | -221.86M | -169.07M |
| Shares Outstanding (Basic) | 112.09M | 111.12M | 94.81M | 84.01M | 68.15M | 63.24M |
| Shares Outstanding (Diluted) | 112.09M | 111.12M | 94.81M | 84.01M | 68.15M | 63.24M |
| EPS (Basic) | -0.15 | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| EPS (Diluted) | -0.15 | -2.01 | -2.73 | -2.92 | -3.26 | -2.67 |
| Free Cash Flow | -170.39M | -190.45M | -215.59M | -211.35M | -186.50M | -128.78M |
| Free Cash Flow Per Share | -1.52 | -1.71 | -2.27 | -2.52 | -2.74 | -2.04 |
| EBITDA | -182.18M | -217.49M | -263.83M | -249.56M | -217.58M | -160.88M |
| D&A For EBITDA | 9.71M | 11.03M | 9.38M | 7.10M | 6.27M | 5.37M |
| EBIT | -191.88M | -228.52M | -273.20M | -256.66M | -223.84M | -166.25M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 224.51M | 77.56M | 163.63M | 55.90M | 140.52M | 232.69M |
| Short-Term Investments | 59.24M | 111.37M | 208.70M | 317.27M | 215.88M | 156.05M |
| Cash & Short-Term Investments | 283.75M | 188.93M | 372.34M | 373.18M | 356.39M | 388.74M |
| Prepaid Expenses | 5.80M | 3.81M | 5.85M | 5.05M | 7.67M | 3.32M |
| Total Current Assets | 289.55M | 192.73M | 378.18M | 378.22M | 364.06M | 392.06M |
| Property, Plant & Equipment | 67.42M | 71.59M | 83.32M | 87.59M | 77.64M | 72.35M |
| Long-Term Investments | 34.32M | 43.28M | ||||
| Goodwill | 39.15M | 39.15M | 39.15M | 39.15M | 39.15M | 30.82M |
| Other Intangible Assets | 25.15M | 25.15M | 25.15M | 25.15M | 25.72M | |
| Other Long-Term Assets | 1.82M | 1.82M | 1.89M | 1.91M | 1.95M | 1.80M |
| Total Assets | 423.10M | 330.45M | 527.70M | 566.34M | 551.81M | 497.02M |
| Accounts Payable | 1.35M | 2.33M | 1.62M | 1.77M | 2.27M | 482.00K |
| Accrued Expenses | 18.37M | 24.91M | 36.02M | 29.80M | 30.54M | 17.81M |
| Current Portion of Leases | 2.98M | 2.92M | 2.86M | 2.72M | 2.51M | 2.55M |
| Current Unearned Revenue | 597.00K | 597.00K | ||||
| Other Current Liabilities | 46.00K | 185.00K | 14.21M | 3.25M | 725.00K | |
| Total Current Liabilities | 31.32M | 30.21M | 40.68M | 48.51M | 39.17M | 22.17M |
| Long-Term Leases | 21.82M | 21.96M | 22.64M | 22.33M | 20.36M | 20.05M |
| Other Long-Term Liabilities | 1.13M | 1.06M | 1.14M | 2.94M | 2.60M | 80.00K |
| Total Liabilities | 54.27M | 53.23M | 64.47M | 73.77M | 62.12M | 42.30M |
| Common Stock | 1.09M | 1.08M | 1.06M | 903.00K | 791.00K | 645.00K |
| Additional Paid-In Capital | 1.73B | 1.72B | 1.68B | 1.45B | 1.20B | 946.15M |
| Retained Earnings | -1.37B | -1.44B | -1.22B | -959.37M | -713.77M | -491.91M |
| Treasury Stock | -47.00K | |||||
| Comprehensive Income & Other | -106.00K | -31.00K | 66.00K | 319.00K | -357.00K | -161.00K |
| Total Common Equity | 368.83M | 277.22M | 463.23M | 492.57M | 489.69M | 454.72M |
| Shareholders' Equity | 368.83M | 277.22M | 463.23M | 492.57M | 489.69M | 454.72M |
| Total Liabilities & Equity | 423.10M | 330.45M | 527.70M | 566.34M | 551.81M | 497.02M |
| Total Debt | 24.80M | 24.88M | 25.50M | 25.04M | 22.87M | 22.60M |
| Net Cash (Debt) | 258.95M | 164.05M | 346.84M | 348.13M | 333.53M | 366.14M |
| Net Cash Per Share | 2.31 | 1.48 | 3.66 | 4.14 | 4.89 | 5.79 |
| Filing Date Shares Outstanding | 109.77M | 108.57M | 106.63M | 90.50M | 79.35M | 64.51M |
| Total Common Shares Outstanding | 109.54M | 108.32M | 106.45M | 90.28M | 79.12M | 64.51M |
| Working Capital | 258.23M | 162.53M | 337.50M | 329.72M | 324.89M | 369.89M |
| Book Value Per Share | 3.37 | 2.56 | 4.35 | 5.46 | 6.19 | 7.05 |
| Tangible Book Value | 304.53M | 212.92M | 398.93M | 428.27M | 424.81M | 423.91M |
| Tangible Book Value Per Share | 2.78 | 1.97 | 3.75 | 4.74 | 5.37 | 6.57 |
| Machinery | 48.16M | 48.06M | 48.85M | 44.58M | 35.61M | 25.21M |
| Leasehold Improvements | 7.33M | 7.33M | 7.28M | 6.72M | 589.00K | 407.00K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -17.25M | -223.12M | -258.75M | -245.59M | -221.86M | -169.07M |
| Depreciation & Amortization | 9.71M | 11.03M | 9.38M | 7.10M | 6.27M | 5.37M |
| Other Amortization | 753.00K | |||||
| Loss (Gain) From Sale of Assets | -178.19M | |||||
| Asset Writedown & Restructuring Costs | 262.00K | 262.00K | 885.00K | 236.00K | 261.00K | |
| Loss (Gain) From Sale of Investments | -4.35M | -6.97M | -8.07M | -10.17M | 134.00K | 2.89M |
| Stock-Based Compensation | 31.78M | 37.06M | 43.92M | 39.41M | 31.01M | 29.24M |
| Other Operating Activities | -1.88M | -364.00K | 12.78M | |||
| Change in Accounts Payable | -12.16M | -10.35M | 6.07M | 10.15M | 9.67M | -4.83M |
| Change in Other Net Operating Assets | -64.00K | 2.09M | -396.00K | 3.67M | -3.60M | 1.44M |
| Operating Cash Flow | -170.27M | -190.01M | -209.72M | -194.92M | -178.14M | -121.16M |
| Capital Expenditures | -127.00K | -440.00K | -5.86M | -16.44M | -8.36M | -7.62M |
| Cash Acquisitions | 42.73M | |||||
| Investment in Securities | 183.79M | 104.21M | 137.57M | -81.59M | -103.43M | 26.57M |
| Other Investing Activities | -36.00K | -261.00K | -95.00K | |||
| Investing Cash Flow | 361.85M | 103.77M | 131.71M | -98.07M | -69.33M | 18.85M |
| Total Debt Repaid | -3.00K | |||||
| Net Debt Issued (Repaid) | -3.00K | |||||
| Issuance of Common Stock | 152.00K | 185.74M | 208.40M | 155.34M | 37.68M | |
| Repurchase of Common Stock | -67.00K | -67.00K | -47.00K | |||
| Other Financing Activities | 215.00K | |||||
| Financing Cash Flow | 82.00K | 148.00K | 185.74M | 208.40M | 155.29M | 37.68M |
| Net Cash Flow | 191.66M | -86.10M | 107.72M | -84.58M | -92.18M | -64.63M |
| Free Cash Flow | -170.39M | -190.45M | -215.59M | -211.35M | -186.50M | -128.78M |
| Free Cash Flow Per Share | -1.52 | -1.71 | -2.27 | -2.52 | -2.74 | -2.04 |
| Levered Free Cash Flow | 86.14M | -104.85M | -133.26M | -119.77M | -99.45M | -82.57M |
| Unlevered Free Cash Flow | 87.32M | -103.67M | -132.08M | -118.60M | -98.29M | -81.47M |
| Cash Interest Paid | 148.00K | |||||
| Change in Working Capital | -12.23M | -8.26M | 5.67M | 13.82M | 6.08M | -3.39M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 271.14M | 379.86M | 1.31B | 2.70B | 1.48B | 1.41B |
| Enterprise Value | 12.19M | 182.15M | 1.10B | 2.29B | 1.20B | 1.01B |
| Last Close Price | 2.44 | 3.51 | 12.57 | 29.97 | 19.57 | 21.83 |
| PB Ratio | 0.72 | 1.37 | 2.83 | 5.49 | 3.02 | 3.09 |
| P/TBV Ratio | 0.89 | 1.78 | 3.29 | 6.31 | 3.49 | 3.32 |
| Debt / Equity Ratio | 0.07 | 0.09 | 0.06 | 0.05 | 0.05 | 0.05 |
| Net Debt / Equity Ratio | -0.70 | -0.59 | -0.75 | -0.71 | -0.68 | -0.81 |
| Net Debt / EBITDA Ratio | 1.42 | 0.75 | 1.31 | 1.40 | 1.53 | 2.28 |
| Net Debt / FCF Ratio | 1.52 | 0.86 | 1.61 | 1.65 | 1.79 | 2.84 |
| Quick Ratio | 9.06 | 6.25 | 9.15 | 7.69 | 9.10 | 17.54 |
| Current Ratio | 9.24 | 6.38 | 9.30 | 7.80 | 9.29 | 17.69 |
| Return on Equity (ROE) | -4.77% | -60.27% | -54.14% | -50.01% | -46.98% | -35.29% |
| Return on Assets (ROA) | -28.42% | -33.29% | -31.21% | -28.69% | -26.68% | -19.10% |
| Return on Capital Employed (ROCE) | -49.00% | -76.10% | -56.10% | -49.60% | -43.70% | -35.00% |
| Earnings Yield | -6.23% | -58.74% | -19.73% | -9.09% | -14.98% | -12.02% |
| FCF Yield | -63.10% | -50.14% | -16.43% | -7.82% | -12.59% | -9.15% |
| Buyback Yield / Dilution | -8.61% | -17.21% | -12.85% | -23.27% | -7.77% | -14.18% |